Crossmark

Emergence of resistance to novel β-lactam/β-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae: clinical and genomic insights from consecutive bloodstream infections

Crossref DOI link: https://doi.org/10.1007/s15010-025-02716-4

Published Online: 2025-12-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Boattini, Matteo

Comini, Sara

Ricciardelli, Guido

Pastrone, Lisa

Casale, Roberto

Guarrasi, Luisa

Cavallo, Rossana

Costa, Cristina

Gaibani, Paolo

Bianco, Gabriele
Funding

Funding for this research was provided by:

Università del Salento
License Information

Text and Data Mining valid from 2025-12-23

Version of Record valid from 2025-12-23
More Information

Article History

Received: 19 November 2025

Accepted: 13 December 2025

First Online: 23 December 2025

Declarations

:

: The authors declare no competing interests.

: This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of A.O.U. Città della Salute e della Scienza di Torino-A.O. Ordine Mauriziano-A.S.L. Città di Torino (protocol code 0048443 on 29 April 2022).

: Informed consent was waived due to the retrospective nature of the study.

Document is current

Any future updates will be listed below